149 related articles for article (PubMed ID: 14567688)
1. Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1.
Blouse GE; Perron MJ; Kvassman JO; Yunus S; Thompson JH; Betts RL; Lutter LC; Shore JD
Biochemistry; 2003 Oct; 42(42):12260-72. PubMed ID: 14567688
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
Kvassman JO; Verhamme I; Shore JD
Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
[TBL] [Abstract][Full Text] [Related]
3. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
[TBL] [Abstract][Full Text] [Related]
4. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
Gils A; Knockaert I; Declerck PJ
Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
[TBL] [Abstract][Full Text] [Related]
5. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
[TBL] [Abstract][Full Text] [Related]
6. Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations.
Huntington JA; Fan B; Karlsson KE; Deinum J; Lawrence DA; Gettins PG
Biochemistry; 1997 May; 36(18):5432-40. PubMed ID: 9154925
[TBL] [Abstract][Full Text] [Related]
7. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
8. The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.
Ibarra CA; Blouse GE; Christian TD; Shore JD
J Biol Chem; 2004 Jan; 279(5):3643-50. PubMed ID: 14594804
[TBL] [Abstract][Full Text] [Related]
9. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition.
Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD
Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300
[TBL] [Abstract][Full Text] [Related]
10. 19F NMR studies of plasminogen activator inhibitor-1.
Abbott GL; Blouse GE; Perron MJ; Shore JD; Luck LA; Szabo AG
Biochemistry; 2004 Feb; 43(6):1507-19. PubMed ID: 14769027
[TBL] [Abstract][Full Text] [Related]
11. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
[TBL] [Abstract][Full Text] [Related]
12. Kinetically controlled folding of the serpin plasminogen activator inhibitor 1.
Wang Z; Mottonen J; Goldsmith EJ
Biochemistry; 1996 Dec; 35(51):16443-8. PubMed ID: 8987976
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
[TBL] [Abstract][Full Text] [Related]
14. Enthalpy measurement using calorimetry shows a significant difference in potential energy between the active and latent conformations of PAI-1.
Sherman WA; Blouse GE; Perron MJ; Tran T; Shore JD; Gafni A
Biol Chem; 2005 Feb; 386(2):111-6. PubMed ID: 15843154
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.
Pedersen KE; Einholm AP; Christensen A; Schack L; Wind T; Kenney JM; Andreasen PA
Biochem J; 2003 Jun; 372(Pt 3):747-55. PubMed ID: 12656676
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.
De Taeye B; Gils A; Vleugels N; Rabijns A; Declerck PJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):746-51. PubMed ID: 15358169
[TBL] [Abstract][Full Text] [Related]
18. Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1.
Einholm AP; Pedersen KE; Wind T; Kulig P; Overgaard MT; Jensen JK; Bødker JS; Christensen A; Charlton P; Andreasen PA
Biochem J; 2003 Aug; 373(Pt 3):723-32. PubMed ID: 12723974
[TBL] [Abstract][Full Text] [Related]
19. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into beta-sheet A.
Lawrence DA; Olson ST; Muhammad S; Day DE; Kvassman JO; Ginsburg D; Shore JD
J Biol Chem; 2000 Feb; 275(8):5839-44. PubMed ID: 10681574
[TBL] [Abstract][Full Text] [Related]
20. Analysis of serpin inhibitory function by mutagenesis of ovalbumin and generation of chimeric ovalbumin/PAI-2 fusion proteins.
McCarthy BJ; Worrall DM
J Mol Biol; 1997 Apr; 267(3):561-9. PubMed ID: 9126838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
